Skip to main content

Table 2 The eradication success rates of regimens

From: The benefit of the bismuth add-on to the 2-week clarithromycin-based triple regimen for Helicobacter pylori eradication: a propensity score-matched retrospective study

Analysis

PACB

PAC

p-value

ITT

(n = 118) 91.5%

(n = 118) 81.4%

0.023

95% CI

0.8643–0.9662

0.7423–0.8849

PP

(n = 111) 97.3%

(n = 109) 88.1%

0.008

95% CI

0.9423–1.00 36

0.8189–0.9426

  1. PACB, clarithromycin-based 2-week triple regimen with bismuth add-on; PAC, clarithromycin-based 2-week triple regimen; ITT, intent-to-treat; PP, per protocol; CI, confidential interval
Back to article page

Gut Pathogens

ISSN: 1757-4749